Overview

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

Assess the efficacy and safety of alefacept with nbUVB compared to alefacept alone in chronic plaque psoriasis subjects. Combination therapy may improve the clinical response to psoriatic subjects as both modalities have an effect on T cells

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Inc

Collaborator:

Astellas Pharma Canada, Inc.

Treatments:

Alefacept